Geode Capital Management LLC Has $6.66 Million Holdings in Regencell Bioscience Holdings Limited $RGC

Geode Capital Management LLC increased its position in shares of Regencell Bioscience Holdings Limited (NASDAQ:RGC - Free Report) by 5,637.5% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 391,066 shares of the company's stock after purchasing an additional 384,250 shares during the period. Geode Capital Management LLC's holdings in Regencell Bioscience were worth $6,664,000 at the end of the most recent reporting period.Get Regencell Bioscience alerts:The Best AI for Picking Stocks, Ranked by PerformanceSeparately, Greenfield Savings Bank acquired a new stake in Regencell Bioscience during the second quarter worth $187,000. Hedge funds and other institutional investors own 0.13% of the company's stock. Wall Street Analysts Forecast GrowthSeparately, Weiss Ratings restated a "sell (e+)" rating on shares of Regencell Bioscience in a research note on Monday. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the company has a consensus rating of "Sell".Read Our Latest Stock Report on Regencell BioscienceRegencell Bioscience Trading Up 1.5%Shares of RGC stock opened at $16.24 on Friday. The company has a fifty day moving average of $15.00. Regencell Bioscience Holdings Limited has a one year low of $0.09 and a one year high of $83.60. Regencell Bioscience Profile (Free Report)Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.Featured ArticlesFive stocks we like better than Regencell BioscienceBiggest Stock Losers - Today’s Biggest Percentage DeclinersRocket Lab’s Big Rebound? Analysts Suggest the Dip's a GiftWhat does consumer price index measure? Meta’s AI Moment? New SAM 3 Model Has Wall Street Turning BullishWhat is the Shanghai Stock Exchange Composite Index?Snowflake Stock: The Dip That Smart Investors Are Buying Right NowThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in Regencell Bioscience Right Now?Before you consider Regencell Bioscience, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Regencell Bioscience wasn't on the list.While Regencell Bioscience currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here